News
1h
LGBTQ Nation on MSNHIV Awareness still belongs at the heart of Pride MonthToday, Pride is still an uprising. Keeping HIV awareness and prevention at the heart of Pride Month deepens its mission and ...
From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 ...
Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier ...
The biggest barrier for those with HIV getting the care they need is not knowing they need it. In response, DAP Health is ...
Word In Black Mystkue Woods words to encourage, educate, and embolden folks take initiative in their sexual health journey by changing ...
The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...
Yeztugo showed promising results in clinical trials. One study involving women in Africa reported 100% efficacy, with zero ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.
In 2012, the FDA approved Truvada, also made by Gilead Sciences, making it the first PrEP medication for HIV prevention in uninfected adults in the United States – but “even though PrEP has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results